Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verve SE | Stockholm | Technology | Software & IT Services | SEK 6.08B | 8.6x | 0.04 | SEK 30.10 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Intrum | Stockholm | Financial | Banking Services | SEK 5.99B | -3.3x | -0.26 | SEK 49.50 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Smartcraft ASA | Stockholm | Technology | Software & IT Services | SEK 4.85B | 47.9x | SEK 29.36 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viaplay AB | Stockholm | Consumer Cyclicals | Media & Publishing | SEK 4.74B | -0.6x | -0.02 | SEK 1.06 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Viaplay AB | Stockholm | Consumer Cyclicals | Media & Publishing | SEK 4.74B | -0.6x | -0.02 | SEK 2 | -33.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bonava A | Stockholm | Real Estate | Real Estate Operations | SEK 3.21B | -2x | -0.03 | SEK 9.06 | -10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Nobia AB | Stockholm | Consumer Cyclicals | Homebuilding & Construction Supplies | SEK 3.07B | -2.3x | -1.48 | SEK 5.10 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.70B | -8x | 0.02 | SEK 40.65 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Egetis Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 1.83B | -5.1x | 0.37 | SEK 6.33 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
24SevenOffice | Spotlight | Technology | Software & IT Services | SEK 1.55B | -13.3x | -0.28 | SEK 22.80 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Sivers IMA | Stockholm | Technology | Semiconductors & Semiconductor Equipment | SEK 1.22B | -7.7x | 0.09 | SEK 5.11 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Kmc Properties ASA | Stockholm | Real Estate | Real Estate Operations | SEK 990.03M | 35.8x | SEK 7.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Airthings | Stockholm | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | SEK 557.96M | -10.8x | SEK 2.92 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acconeer | Stockholm | Technology | Electronic Equipment & Parts | SEK 553.18M | -7.7x | -0.35 | SEK 8.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Opticept Technologies | Stockholm | Consumer Non-Cyclicals | Food & Tobacco | SEK 289.11M | -3.3x | -0.07 | SEK 6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Krona Public Real Estate | Spotlight | SEK 228.69M | -2.2x | 0.01 | SEK 51 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 216.90M | -4.4x | -0.07 | SEK 5.30 | 10.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Adverty | NGM | Technology | Software & IT Services | SEK 181.96M | -40.8x | -0.51 | SEK 5.72 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Prolight Diagnostics | NGM | Healthcare | Biotechnology & Medical Research | SEK 170.23M | -0.7x | 0 | SEK 0.28 | -9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
CS Medica AS | Spotlight | Healthcare | Pharmaceuticals | SEK 165.28M | -4.6x | 0.16 | SEK 13.41 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Fragbite Group AB | Stockholm | Technology | Software & IT Services | SEK 143.59M | -0.1x | -0 | SEK 0.04 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
AroCell | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 124.39M | -2.2x | -1.19 | SEK 0.54 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Alzinova | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 112.22M | -6.3x | -0.28 | SEK 2.54 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
NextCell Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 110.37M | -1.3x | 1.04 | SEK 1.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Anoto | Stockholm | Technology | Office Equipment | SEK 102.54M | -1.3x | 0.04 | SEK 0.31 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
New Bubbleroom Sweden AB | Stockholm | Technology | Software & IT Services | SEK 86.28M | -2.9x | -0.22 | SEK 5.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Biosergen AS | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 86M | -0.6x | -0.07 | SEK 0.54 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bio Vitos Pharma AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 85.85M | -2.8x | -0.08 | SEK 0.29 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 72.76M | -0.6x | -0.02 | SEK 0.88 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
QBNK Holding AB | Spotlight | Technology | Software & IT Services | SEK 60.95M | -20.7x | -0.45 | SEK 6.25 | -20.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |